US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.62

+0.99512.96%

Post-market: 34.620.00000.00%19:30 EDT

Volume:31.48K

Turnover:1.09M

Market Cap:111.48M

PE:- -

High:34.68

Open:33.80

Low:33.71

Close:33.62

52wk High:36.84

52wk Low:25.00

Shares:3.22M

Float Shares:3.22M

Volume Ratio:0.39

T/O Rate:0.98%

Dividend:0.39

Dividend Rate:1.13%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Regeneron Pharmaceuticals (REGN) Gets A Fresh Look As Trial Wins And Sanofi Deal Feed Value Narrative

Simply Wall St.

11% Undervalued? Vertex Pharmaceuticals (VRTX) Following New ALYFTREK Data

Simply Wall St.

Amgen Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Advances 14.2%, Outperforms Peers

Vertex Pharmaceuticals to present data on Alyftrek at NACFC

Vertex Says Interim Alyftrek Study Data Show Some CF Children Ages 2-5 Regain Pancreatic Function

Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors

Retension Pharmaceuticals Debuts on US Stock Market, Shares Drop Over 10% After Opening

Sino Biopharmaceutical Stock Falls 1.4% in Hong Kong

Amgen (AMGN) In Focus As MariTide Buzz Tests Whether The Stock Is Fully Valued

Simply Wall St.

Vertex to Raise Up to C$7 Million in Subordinated Loan with Attached Warrants

Press Release: Vertex Resource GROUP LTD. Announces Subordinated TERM LOAN of up to C$7,000,000

Amgen’s Monthly Diabetes Shot Takes Aim at Semaglutide in New Phase 3 Trial

Dow's Nearly 150-Point Fall Led by Losses for Shares of Amgen, Johnson & Johnson

Starbucks Explored Acquisition of Chipotle in Bid to Create Restaurant Industry Mega-Merger

Lepu Medical's Subsidiary Gains FDA Clearance for Clinical Trial of MWN117 Injection

Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM)

Amgen Stock Forecast: Pipeline Wins Strengthen Growth Story as MariTide Phase 3 Advances

Zhongsheng Pharmaceutical's Class 1 Innovative Drug RAY1225 Injection Achieves Topline Analysis Results in Phase III Weight Loss Clinical Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/IBBQ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.62,"timestamp":1791576000000,"preClose":33.6249,"halted":0,"volume":31484,"hourTrading":{"tag":"盘后","latestPrice":34.62,"preClose":34.62,"latestTime":"19:30 EDT","volume":37,"amount":1289.62,"timestamp":1791588605827,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.029594140056922128,"floatShares":3220001,"shares":3220001,"eps":0,"marketStatus":"Market Closed","change":0.9951,"latestTime":"10-09 16:00:00 EDT","open":33.8,"high":34.68,"low":33.7079,"amount":1085852.840908,"amplitude":0.02891,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":33.6249,"sharesOutstanding":2520001,"nav":33.62265,"aum":111665382.5,"dividendRate":0.011265,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.62,"preClose":34.62,"latestTime":"19:30 EDT","volume":37,"amount":1289.62,"timestamp":1791588605827,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.39329730648058625,"impliedVol":0.14,"impliedVolPercentile":0.6255},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":3220001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.39329730648058625,"shares":3220001,"dividePrice":0.39,"high":34.68,"amplitude":0.02891,"preClose":33.6249,"low":33.7079,"week52Low":25,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.62,"eps":0,"divideRate":0.011265,"volume":31484,"delay":0,"ttmEps":0,"open":33.8,"prevYearClose":28.3962,"prevWeekClose":34.37,"prevMonthClose":35.14,"prevQuarterClose":35.14,"fiveDayClose":34.37,"twentyDayClose":34.472,"sixtyDayClose":32.59},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"IBBQ","amount":0.23037,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674815517","title":"Regeneron Pharmaceuticals (REGN) Gets A Fresh Look As Trial Wins And Sanofi Deal Feed Value Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2674815517","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674815517?lang=en_us&edition=fundamental","pubTime":"2026-10-11 07:25","pubTimestamp":1791674706,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) has landed a cluster of high profile updates in October 2026, from early ubamatamab and trevogrumab trial readouts to a larger immunology antibody alliance with Sanofi, backed by a US$1b upfront payment.\nAll of this is landing while Regeneron Pharmaceuticals trades at US$746.54, with the share price up over the past quarter but down over the year to date. The 1 year total shareholder return of 32.9% indicates that momentum may be building again as investors...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/33715-card/1789122008118","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/33715-card/1789122008118"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/regeneron-pharmaceuticals-regn-gets-a-fresh-look-as-trial-wi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/regeneron-pharmaceuticals-regn-gets-a-fresh-look-as-trial-wi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0058720904.USD","IBB","LU0053666078.USD","LU1917777945.USD","LU0114720955.EUR","LU2023250504.SGD","LU0823434583.USD","BK4588","SNYNF","LU2362541273.HKD","BK4139","LU0320765992.SGD","LU0109394709.USD","LU2468319806.SGD","LU2362540622.SGD","IBBQ","LU1974910355.USD","LU0823416689.USD","TBXU","LU0889565916.HKD","LU2106854487.HKD","BK4585","LU2237438978.USD","LU2362541513.USD","BK4007","LU0289739699.SGD","LU2324357040.USD","BBH","REGN","LU0882574055.USD","LU2089984988.USD","LU0823434740.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674889959","title":"11% Undervalued? Vertex Pharmaceuticals (VRTX) Following New ALYFTREK Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2674889959","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674889959?lang=en_us&edition=fundamental","pubTime":"2026-10-10 15:30","pubTimestamp":1791617441,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) just put fresh clinical data for ALYFTREK in front of cystic fibrosis specialists at the North American Cystic Fibrosis Conference, highlighting early pancreatic function recovery in some very young children.\nVertex Pharmaceuticals’ recent ALYFTREK data arrives while the share price has climbed 12.82% year to date and the 1-year total shareholder return of 25.08% points to solid momentum, with a 5.09% 90-day share price return suggesting that investors are...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/36235-card/1788967613256","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/36235-card/1788967613256"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/11-undervalued-vertex-pharmaceuticals-vrtx-following-new-aly","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/11-undervalued-vertex-pharmaceuticals-vrtx-following-new-aly","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0889565916.HKD","LU1585245621.USD","IDNA","IE00B19Z9Z06.USD","LU2362541513.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IBB","BK4588","IE00BZ9MQY76.HKD","LU1093756168.USD","LU0823416689.USD","LU1069344957.HKD","LU0058720904.USD","LU2089984988.USD","LU2462157665.USD","VERX","VRTX","LU2456880835.USD","LU1093756325.SGD","LU2362541273.HKD","LU0757428866.USD","GNMX","IE0009355771.USD","BK4023","IE00B894F039.SGD","BBH","LU0289739699.SGD","IE00B19Z9P08.USD","BK4567","LU0109394709.USD","LU1559883803.SGD","BK4139","LU1674673428.USD","BIB","IBBQ","TBXU","LU2236285917.USD","LU2417539215.USD","BK4532","LU1778281490.HKD","PBE","LU0234570918.USD","LU0061475181.USD","LU1674673691.USD","IE0002270589.USD","LU0566484027.USD","IE00BJT1NW94.SGD","BK4585","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674861455","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2674861455","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674861455?lang=en_us&edition=fundamental","pubTime":"2026-10-10 04:34","pubTimestamp":1791578040,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  advanced 1.82% to $414.87 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.59% to 7,811.54 and the Dow Jones Industrial Average  rising 0.83% to 51,654.95.Amgen Inc. closed 7.19% short of its 52-week high of $447.03, which the company reached on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  rose 1.93% to $261.44, Pfizer Inc.  rose 1.65% to $28.28, and AbbVie Inc.  rose 1.49% to $276.47.Trading volume  remained 824,175 below its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 9, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","PJP","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4581","IBBQ","BK4534","IE0002141913.USD","PBE","LU0109394709.USD","BIB","BBH","LU2089984988.USD","IBB","LU1061106388.HKD","IE00BFTCPJ56.SGD","04332","IE00B2B36J28.USD","BK4588","LU0320765992.SGD","LU1571399168.USD","LU2468319806.SGD","IE0009355771.USD","SG9999001440.SGD","LU2242646821.SGD","BK4599","LU0122379950.USD","LU0868494617.USD","LU0289739699.SGD","LU1057294990.SGD","IE00B4R5TH58.HKD","BK4533","BK4585","LU2112291526.USD","LU2242652126.USD","LU1983299246.USD","AMGN","LU1023059063.AUD","TBXU","LU0889565916.HKD","BK4139","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674614538","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2674614538","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674614538?lang=en_us&edition=fundamental","pubTime":"2026-10-10 04:34","pubTimestamp":1791578040,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 2.77% to $151.17 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.59% to 7,811.54 and the Dow Jones Industrial Average  rising 0.83% to 51,654.95.This was the stock's third consecutive day of gains.Gilead Sciences Inc. closed 3.89% short of its 52-week high of $157.29, which the company reached on February 11th.The stock outperformed some of its competitors Friday, as Johnson & Johnson  rose 1.93% to $261.44, Pfizer Inc.  rose 1.65% to $28.28, and Abbott Laboratories  rose 1.13% to $99.60.Trading volume  remained 643,432 below its 50-day average volume of 6.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 9, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU0114720955.EUR","IBBQ","IE00B7SZLL34.SGD","LU1674673691.USD","LU0109394709.USD","IE00B3T34201.USD","TMED","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU0859254822.USD","LU1585245621.USD","BIB","LU0234570918.USD","LU0882574055.USD","BBH","LU0965509283.SGD","SG9999015978.USD","LU0965509101.SGD","LU2089984988.USD","IBB","LU1061106388.HKD","SG9999015952.SGD","BK4550","LU0058720904.USD","LU2087621335.USD","IE0002270589.USD","LU0861579265.USD","LU1934455277.USD","LU1934455863.HKD","LU0965508806.USD","SG9999015986.USD","BK4588","LU1839511570.USD","LU0320765992.SGD","LU1571399168.USD","IE00B19Z3B42.SGD","LU1037948541.HKD","LU2468319806.SGD","MEDI","LU0965509010.AUD","LU1674673428.USD","LU0122379950.USD","BK4583","LU1066053197.SGD","LU1037948897.HKD","LU2324357040.USD","LU0289739699.SGD","LU1057294990.SGD","LU2357627491.SGD","LU1430594728.SGD","LU1066051498.USD","IE00BSNM7G36.USD","BK4568","BK4532","BMED","BK4585","BK4578","LU2112291526.USD","LU1778281490.HKD","SG9999015945.SGD","LU1023059063.AUD","TBXU","LU0823416689.USD","LU0889565916.HKD","BK4139","IE00BKVL7J92.USD","LU1934455194.USD","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674861788","title":"Moderna Inc. Stock Advances 14.2%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2674861788","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674861788?lang=en_us&edition=fundamental","pubTime":"2026-10-10 04:32","pubTimestamp":1791577920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. jumped 14.2% to $225.00 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.6% to 27,366.17 and the Dow Jones Industrial Average rising 0.8% to 51,654.95.This was the stock's third consecutive day of gains.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $212.22, which the company achieved on October 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.9% to $261.44, Pfizer Inc. rose 1.7% to $28.28, and Gilead Sciences Inc. rose 2.77% to $151.17.Trading volume totaled 28.7 million, compared to the 50-day average of 21.5 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IE00B3T34201.USD","LU1934455863.HKD","LU1674673691.USD","BMED","LGHT","BK4139","LU1023059063.AUD","MRNA","MRNX","LU0965508806.USD","MEDI","BK4551","LU0965509010.AUD","LU2468319806.SGD","LU0289739699.SGD","IE00BSNM7G36.USD","LU0965509101.SGD","SG9999015952.SGD","LU2087621335.USD","LU1839511570.USD","BK4501","LU0882574055.USD","IE00B19Z3B42.SGD","MRNY","TMED","IE0002270589.USD","LU1057294990.SGD","LU1571399168.USD","GILD","LU1778281490.HKD","BK4548","LU1066051498.USD","IDNA","WDNA","LU1934455277.USD","LU0234570918.USD","SG9999015945.SGD","BK4533","IE00B19Z3581.USD","LU1934455194.USD","GNOM","BK4532","BBH","LU2357627491.SGD","IBBQ","LU0965509283.SGD","IBB","TBXU","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674866511","title":"Vertex Pharmaceuticals to present data on Alyftrek at NACFC","url":"https://stock-news.laohu8.com/highlight/detail?id=2674866511","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674866511?lang=en_us&edition=fundamental","pubTime":"2026-10-10 01:20","pubTimestamp":1791566419,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) announced new interim data from the ALYFTREK 2 to 5 years old open-label extension study, highlighting recovery of ex...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-to-present-data-on-alyftrek-at-nacfc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-to-present-data-on-alyftrek-at-nacfc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","IE00B4R5TH58.HKD","IBB","IE00B894F039.SGD","IE00BZ9MQY76.HKD","LU1093756325.SGD","LU0109394709.USD","LU1778281490.HKD","SG9999013999.USD","LU0320765992.SGD","LU0432979614.USD","LU1674673428.USD","IE00B19Z9P08.USD","LU0256863811.USD","LU1674673691.USD","LU2237438978.USD","TBXU","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","BK4023","LU0417517546.SGD","PBE","IE00BJT1NW94.SGD","LU2236285917.USD","IE0002270589.USD","LU2468319806.SGD","LU0061475181.USD","IE0009355771.USD","BK4139","BK4532","BIB","VRTX","LU2324357040.USD","SG9999001176.USD","IE00BFTCPJ56.SGD","LU0234570918.USD","IDNA","VERX","LU1585245621.USD","BBH","BK4588","LU1035775433.USD","GNMX","IE00B2B36J28.USD","LU0289739699.SGD","BK4567","SG9999001176.SGD","LU2089984988.USD","IBBQ","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674865094","title":"Vertex Says Interim Alyftrek Study Data Show Some CF Children Ages 2-5 Regain Pancreatic Function","url":"https://stock-news.laohu8.com/highlight/detail?id=2674865094","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674865094?lang=en_us&edition=fundamental","pubTime":"2026-10-10 01:15","pubTimestamp":1791566131,"startTime":"0","endTime":"0","summary":"Vertex says interim ALYFTREK study data show some CF children ages 2-5 regain pancreatic functionVertex flagged interim trial data on ALYFTREK showing some cystic fibrosis children ages 2 to 5 regaine","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nNDL2tJqZ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","LU0432979614.USD","LU2324357040.USD","IE00BJT1NW94.SGD","LU1674673428.USD","LU1778281490.HKD","IE00B19Z3581.USD","IE00BZ9MQY76.HKD","LU2237438978.USD","BIB","LU2362541513.USD","LU1069344957.HKD","SG9999013999.USD","LU0061475181.USD","IE00B19Z9Z06.USD","BK4585","LU0079474960.USD","LU1093756168.USD","LU2089984988.USD","LU2362541273.HKD","LU0889565916.HKD","BK4533","BBH","GNMX","LU0109394709.USD","LU2417539215.USD","LU0417517546.SGD","SG9999001176.SGD","IE0002141913.USD","IBBQ","VRTX","LU2468319806.SGD","IBB","TBXU","IDNA","BK4532","BK4139","IE00B894F039.SGD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0320765992.SGD","LU0823416689.USD","IE00B4R5TH58.HKD","LU2462157665.USD","IE0002270589.USD","PBE","LU0234570918.USD","LU0058720904.USD","LU1674673691.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674902865","title":"Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2674902865","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674902865?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:30","pubTimestamp":1791563440,"startTime":"0","endTime":"0","summary":"Moderna ($MRNA), Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. The Phase 1/2 study titled “A Phase 1/2 D...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-and-moderna-advance-cf-mrna-therapy-what-vx-522-trial-completion-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-and-moderna-advance-cf-mrna-therapy-what-vx-522-trial-completion-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","WDNA","LU1778281490.HKD","IE00B894F039.SGD","MRNA","GNMX","BK4548","IBB","GNOM","IE00BJT1NW94.SGD","LU0889565916.HKD","BK4567","LU0320765992.SGD","BK4501","TBXU","BK4585","MRNX","LGHT","IBBQ","LU1069344957.HKD","IE00B4R5TH58.HKD","LU0566484027.USD","LU2324357040.USD","LU2362540622.SGD","LU1585245621.USD","MRNY","BK4551","IDNA","IE00B2B36J28.USD","LU2237438978.USD","LU0757428866.USD","PBE","SG9999001176.SGD","VERX","LU0061475181.USD","LU0823416689.USD","LU0289739699.SGD","BBH","LU1093756168.USD","ISBC","LU2362541513.USD","BK4139","BIB","IE00BFTCPJ56.SGD","IE0002270589.USD","LU2362541273.HKD","VRTX","IE00B19Z9P08.USD","IE00BJJMRZ35.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144830990","title":"Retension Pharmaceuticals Debuts on US Stock Market, Shares Drop Over 10% After Opening","url":"https://stock-news.laohu8.com/highlight/detail?id=1144830990","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144830990?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:28","pubTimestamp":1791563294,"startTime":"0","endTime":"0","summary":"According to reports, on Friday, Retension Pharmaceuticals Inc (RTSN.US) listed on the US stock market. As of press time, the stock had fallen more than 10% to $10.77. The IPO price was $12.Retension...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","RTSN","MRNY","BBP","03069","IBBQ","BK1610"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674328258","title":"Sino Biopharmaceutical Stock Falls 1.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2674328258","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674328258?lang=en_us&edition=fundamental","pubTime":"2026-10-09 16:33","pubTimestamp":1791534780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.4% to 5.41 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.8% to 24211.35.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 33% short of its 52-week high of HK$8.08, which the company reached Oct. 10.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 2.2% and Amgen Inc. remained unchanged.Trading volume totaled 72.7 million shares, compared to the 50-day average of 80.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","LU1983299246.USD","IE00B2B36J28.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","AMGN","LU0058720904.USD","IE00BJT1NW94.SGD","BK4139","BK1515","BK4599","HK0000165453.HKD","IE0009355771.USD","LU2468319806.SGD","PJP","BBH","IBBQ","BK4534","LU0320765992.SGD","BK4581","LU0868494617.USD","LU1057294990.SGD","LU0122379950.USD","01177","BK1191","BIB","IE00BZ08YR35.GBP","LU2242652126.USD","IE00BZ08YT58.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","BK4533","IE00BJJMRZ35.SGD","BK4585","LU0289739699.SGD","BK4588","LU2112291526.USD","IE0002141913.USD","BK4566","LU2089984988.USD","IBB","BK1521","IE00BZ08YS42.EUR","LU1023059063.AUD","TBXU","SG9999001440.SGD","PBE","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674488039","title":"Amgen (AMGN) In Focus As MariTide Buzz Tests Whether The Stock Is Fully Valued","url":"https://stock-news.laohu8.com/highlight/detail?id=2674488039","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674488039?lang=en_us&edition=fundamental","pubTime":"2026-10-09 10:36","pubTimestamp":1791513400,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) is back in focus after fresh attention on its obesity drug candidate MariTide, now in late-stage Phase III testing, and new precision medicine partnerships that together are shaping sentiment toward the stock.\nThose headlines are landing on a stock that has already been rebuilding confidence. Amgen’s share price is up 12.12% over 90 days and 24.36% year to date, while its 1-year total shareholder return of 41.74% points to strong, dividend-backed momentum rather than a...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/24816-card/1789038959684","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/24816-card/1789038959684"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/amgen-amgn-in-focus-as-maritide-buzz-tests-whether-the-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amgn/amgen/news/amgen-amgn-in-focus-as-maritide-buzz-tests-whether-the-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4566","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4534","LU0889565916.HKD","LU2468319806.SGD","LU2112291526.USD","BBH","LU1571399168.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","AMGN","PBE","BK4585","LU1983299246.USD","SG9999001440.SGD","IBB","LU0289739699.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","IBBQ","TBXU","LU0868494617.USD","LU1057294990.SGD","LU2089984988.USD","LU0058720904.USD","LU0109394709.USD","LU0122379950.USD","BK4533","PJP","LU1061106388.HKD","LU2242646821.SGD","IE00BJT1NW94.SGD","BIB","BK4581","BK4599","BK4588","BK4139","LU1023059063.AUD","IE0009355771.USD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674886821","title":"Vertex to Raise Up to C$7 Million in Subordinated Loan with Attached Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2674886821","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674886821?lang=en_us&edition=fundamental","pubTime":"2026-10-09 07:38","pubTimestamp":1791502698,"startTime":"0","endTime":"0","summary":"An update from Vertex Resource Group Ltd. ( ($TSE:VTX) ) is now available. Vertex Resource Group Ltd., a North American environmental services firm...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-to-raise-up-to-c7-million-in-subordinated-loan-with-attached-warrants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-to-raise-up-to-c7-million-in-subordinated-loan-with-attached-warrants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0417517546.SGD","LU1674673428.USD","SG9999001176.USD","TBXU","LU1778281490.HKD","PBE","LU2468319806.SGD","IE0002141913.USD","IE00B894F039.SGD","IE00B19Z3B42.SGD","IBB","VRTX","LU2462157665.USD","LU0058720904.USD","BK4585","BK4588","BBH","LU0757428866.USD","IE00B2B36J28.USD","LU2456880835.USD","LU1815336091.USD","IE0009355771.USD","LU1035775433.USD","SGXZ57979304.SGD","LU2362541273.HKD","LU0061475181.USD","LU1093756168.USD","BK4139","LU2089984988.USD","IE00B19Z3581.USD","LU1430594728.SGD","LU1559883803.SGD","LU0566484027.USD","LU0256863811.USD","IE00B19Z9P08.USD","LU0432979614.USD","LU2362541513.USD","IBBQ","LU2417539215.USD","IE00B4R5TH58.HKD","LU2237438978.USD","BK4567","SG9999013999.USD","BK4532","VERX","IE00BJT1NW94.SGD","BIB","IDNA","GNMX","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674883067","title":"Press Release: Vertex Resource GROUP LTD. Announces Subordinated TERM LOAN of up to C$7,000,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2674883067","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674883067?lang=en_us&edition=fundamental","pubTime":"2026-10-09 06:30","pubTimestamp":1791498600,"startTime":"0","endTime":"0","summary":"SHERWOOD PARK, AB, Oct. 8, 2026 /CNW/ -- (TSXV: VTX) -- Vertex Resource Group Ltd. (\"Vertex\" or the \"Corporation\") announces its intention to enter into a subordinated credit arrangement with Factory ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","VRTX","GNMX","IE0002270589.USD","BBH","BIB","LU2468319806.SGD","SG9999013999.USD","BK4567","IE00BZ9MQY76.HKD","LU2456880835.USD","LU1674673691.USD","LU2237438978.USD","91512","LU0757428866.USD","SGXZ57979304.SGD","LU0061475181.USD","SG9999001176.SGD","LU2362541273.HKD","BK4588","LU0320765992.SGD","LU1674673428.USD","BK4585","LU0432979614.USD","IE0002141913.USD","IDNA","LU0109394709.USD","IE0009355771.USD","SG9999001176.USD","LU0566484027.USD","LU1093756325.SGD","VERX","IE00B4R5TH58.HKD","91013","IE00B894F039.SGD","LU1585245621.USD","BK4533","LU0289739699.SGD","IBBQ","PBE","BK4139","IE00B19Z9Z06.USD","LU0079474960.USD","LU1778281490.HKD","LU2462157665.USD","LU2362540622.SGD","TBXU","IE00BJT1NW94.SGD","LU2417539215.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674009023","title":"Amgen’s Monthly Diabetes Shot Takes Aim at Semaglutide in New Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2674009023","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674009023?lang=en_us&edition=fundamental","pubTime":"2026-10-09 00:31","pubTimestamp":1791477115,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen lines up a head-to-head diabetes trial that could reshape the GLP-1 la...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-monthly-diabetes-shot-takes-aim-at-semaglutide-in-new-phase-3-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-monthly-diabetes-shot-takes-aim-at-semaglutide-in-new-phase-3-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0868494617.USD","LU1057294990.SGD","BK4588","BK4581","JDOC","LU2112291526.USD","BK4139","IE00B2B36J28.USD","BK4599","IE00B4R5TH58.HKD","PJP","LU0109394709.USD","BIB","LU1061106388.HKD","BK4585","LU2089984988.USD","IE00BJT1NW94.SGD","TBXU","BK4566","LU0320765992.SGD","BK4533","IE0009355771.USD","LU1571399168.USD","LU2242652126.USD","LU0889565916.HKD","AMGN","IBB","IE0002141913.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU1983299246.USD","BBH","BK4534","LU0289739699.SGD","LU2242646821.SGD","LU1023059063.AUD","LU0122379950.USD","LU0058720904.USD","PBE","IBBQ","SG9999001440.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673800513","title":"Dow's Nearly 150-Point Fall Led by Losses for Shares of Amgen, Johnson & Johnson","url":"https://stock-news.laohu8.com/highlight/detail?id=2673800513","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673800513?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:51","pubTimestamp":1791471060,"startTime":"0","endTime":"0","summary":"DJ Dow's Nearly 150-Point Fall Led By Losses For Shares Of Amgen, Johnson & JohnsonThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen and Johnson & Johnson are trading lower Thursday morning, dragging the Dow Jones Industrial Average into negative territory.The Dow  was most recently trading 142 points, or 0.3%, lower, as shares of Amgen  and Johnson & Johnson  have contributed to the index's intraday decline.Amgen's shares are off $10.59, or 2.6%, while those of Johnson & Johnson are down $5.85, or 2.3%, combining for a roughly 98-point drag on the Dow.Also contributing significantly to the decline are Merck , UnitedHealth , and Boeing .A $1 move in any of the benchmark's 30 components equates to a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled October 8, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","LU0912757837.SGD","LU0466842654.USD","IYH","IE000F7OJYX1.SGD","IE00BBT3K403.USD","LU2112291526.USD","LU0124676726.USD","IE0001KFT4U8.USD","LU2430703095.HKD","VUG","IXJ","LU0098860793.USD","GDOC","PJP","VYMI","LU1674673428.USD","LU0640476718.USD","SG9999002232.USD","SGXZ80539844.SGD","IE0002270589.USD","LU0345769128.USD","LU1121112475.USD","LU1244550494.USD","ITA","LU1228905540.USD","LU2403377893.USD","TBXU","TOPT","LU0545039389.USD","LU1585245621.USD","LU0545562505.USD","MGK","FTXH","LU0889565916.HKD","LU1032955483.USD","LU1228905037.USD","IE00BVYPNV92.GBP","BA","IE000SO60NU8.SGD","BBH","SCHG","LU0072461881.USD","IE00BKVL7J92.USD","LU0553294199.USD","LU1629891620.HKD","LU2347655156.SGD","PPA","LU1023059063.AUD","LU0472753341.HKD","LU1162221912.USD","SG9999002224.SGD","LU0122379950.USD","LU0661504455.SGD","BK4532","SDOW","LU2430703251.USD","LU2505996509.AUD","LU2756315664.SGD","LU0426412945.USD","LU1280957306.USD","LU0114720955.EUR","LU0210528500.USD","LU1074936037.SGD","YMAX","LU0868494617.USD","VHT","LU0820561818.USD","BK4581","JNJ","LU0320765646.SGD","FHLC","IE00BN8TJ469.HKD","IE00BSNM7G36.USD","IE000M9KFDE8.USD","BK4599","LU1929549753.HKD","IE00BVYPNW00.USD","LU2129689605.HKD","LU0985320562.USD","LU2505996681.GBP","LU0109394709.USD","BIB","BK4559","LU0057025933.USD","BK4585","LU1989771016.USD","LU0210536198.USD","LU1267930813.SGD","LU2089984988.USD","LU1778281490.HKD","RXL","BOED","LU1732799900.SGD","XLI","LU0320765992.SGD","LU1430594728.SGD","LU2750360997.AUD","LU2326559502.SGD","BK4551","UDOW","AMGN","IE0002141913.USD","FDVV",".DJI","BK4007","BK4564","LU0792757196.USD","SDY","DVY","LU0203347892.USD","BK4534","LU1496350502.SGD","LU2242646821.SGD","IDEF","LU0964807845.USD","BK4592","BK4187","IE000MB6IJN5.SGD","BK4504","LU1043141396.HKD","LU1506573853.SGD","LU2133065610.SGD","DJX","LU1551013342.USD","DIA","FOWF","DGRO","IBBQ","LU0345769631.USD","GRNY","LU0795875169.SGD","LU2236285917.USD","LU2750360641.GBP","SG9999001440.SGD","LU2756315318.SGD","IE00B7SZLL34.SGD","LU2471134952.CNY","MEDX","LU1057294990.SGD","BMED","LU0795875086.SGD","BK4139","LU1059921491.USD","LU0787776722.HKD","LU2602419157.SGD","IE00B4R5TH58.HKD","LU1032466523.USD","LU0820561909.HKD","LU0882574055.USD","LU0345770993.USD","LU1894683348.USD","IE00BLSP4452.SGD","04332","DGRW","LU1061106388.HKD","LU1066051811.HKD","LU1551013425.SGD","LU0289739343.SGD","LU1914381329.SGD","LU2129689431.USD","LU2471134796.USD","LU1066051225.USD","BOEG","IE000WAW04H5.SGD","DOG","BK4533","BK4568","IE0009355771.USD","LU0943347566.SGD","LU0432979614.USD","LU2430703178.SGD","IBB","LU2456880835.USD","LU0994945656.USD","LU1983299246.USD","LU2129689514.USD","XLV","BK4516","MYMmain","IE00BFXG1179.USD","LU0053666078.USD","LU2896262040.SGD","IE00B42XCP33.USD","IHE","LU0689626769.HKD","IE00B3PB1722.GBP","LU2592432038.USD","SG9999013999.USD","LU2487616109.SGD","LU0889566641.SGD","IE00B1BXHZ80.USD","LU1674673691.USD","IE00BDGV0183.EUR","DJIA","LU1003077747.HKD","VYM","LU1221951046.USD","LU0820562030.AUD","LU2023250330.USD","BK4588","BOEU","LU1196500208.SGD","LU0345770308.USD","JDOC","LU1935042991.SGD","LU0949170772.SGD","IE00B2B36J28.USD","IE00B19Z3581.USD","TRUH","LU0289961442.SGD","LU1043141123.HKD","LU0069063385.USD","LU1718418525.SGD","SG9999001176.SGD","LU0689472784.USD","LU0426417589.USD","IE0000B7K699.USD","IE00BGHQF631.EUR","LU0683600562.USD","IE00BZ1G4Q59.USD","LU1732800096.USD","LU1429558221.USD","LU2471134523.USD","LU1221951129.SGD","NATO","MISL","DDM","LU1894683264.USD","IE00BJT1NW94.SGD","LU0070217475.USD","LU1291159041.SGD","SCHD","BK4566","LU2417539215.USD","LU1571399168.USD","IE00B19Z3B42.SGD","LU2242652126.USD","LU1066051498.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU1435385759.SGD","LU1244550221.USD","LU0511384066.AUD","LU2213496289.HKD","SG9999001176.USD","BK4550","DXD","LU0289739699.SGD","LU0162691827.USD","LU1261432733.SGD","LU2471134879.HKD","LU1066053197.SGD","FDN","IE00B3T34201.USD","LU0738911758.USD","LU0058720904.USD","PBE","LU1244550577.SGD","IE0034235303.USD","IE00BJJMRZ35.SGD","LU0234570918.USD","LU1145028129.USD","IE000BZT7R73.USD","SGXZ57979304.SGD","IE00BLSP4239.USD","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178666966","title":"Starbucks Explored Acquisition of Chipotle in Bid to Create Restaurant Industry Mega-Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1178666966","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178666966?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:20","pubTimestamp":1791469222,"startTime":"0","endTime":"0","summary":"Starbucks held discussions about acquiring Chipotle Mexican Grill, a grand plan that would merge two of America's most recognized consumer brands and, if completed, would rank as the largest merger...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BREW","TMED","BK4535","CANC","BK4209","BK4504","MNA","MMID","RFG","UYG","DFMC","BK4610","FFSM","LU0882574139.USD","TBXU","LU0823411888.USD","IBBQ","AAUM","PSP","ACTV","SBUX","EATZ","BK4588","PEVC","PRVT","SBU","VXF","IYH","IEFN","RSPH","PBJ","XLFI","BK4585","IE00B3T34201.USD","GTPE","PBPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182207516","title":"Lepu Medical&#39;s Subsidiary Gains FDA Clearance for Clinical Trial of MWN117 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1182207516","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182207516?lang=en_us&edition=fundamental","pubTime":"2026-10-08 21:52","pubTimestamp":1791467534,"startTime":"0","endTime":"0","summary":"Lepu Medical Technology (Beijing) Co., Ltd. (300003.SZ) announced today that its controlling subsidiary, Shanghai Minwei Biotechnology Co., Ltd., has received a Study May Proceed Letter from the U.S....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK0028","IBBJ","BMED","300003","LABU","BK0113","BK0196","PSYK","BK0251","BK4585","BK4588","MDTX","BK0042","BK0188","BK0201","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673133072","title":"Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673133072","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673133072?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:10","pubTimestamp":1791461430,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD) and Rhythm Pharmaceuticals (R...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-gilead-sciences-gild-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-gilead-sciences-gild-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999015986.USD","BIB","IE00B3T34201.USD","LU1066053197.SGD","LU1934455863.HKD","BMED","LU1023059063.AUD","LU0823416689.USD","LU2324357040.USD","LU0965508806.USD","MEDI","LU0965509010.AUD","LU2468319806.SGD","RYTM","IE00B7SZLL34.SGD","HCSG","LABU","LU0882574055.USD","SG9999015978.USD","IE00B19Z3B42.SGD","BK4137","LU2112291526.USD","IE00BZ1G4Q59.USD","IE0002270589.USD","TMED","BK4568","LU0058720904.USD","XBI","BK4583","GILD","XLV","LU1934455277.USD","LU0320765992.SGD","LU0234570918.USD","LU1934455194.USD","IE00B19Z3581.USD","BK4532","BBH","LU2089984988.USD","LU2357627491.SGD","IBBQ","LU1674673428.USD","LU0029874061.USD","LU1037948897.HKD","LU0965509283.SGD","BK4566","IBB","BK4585","TBXU","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673072511","title":"Amgen Stock Forecast: Pipeline Wins Strengthen Growth Story as MariTide Phase 3 Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2673072511","media":"TradingKey","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673072511?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460800,"startTime":"0","endTime":"0","summary":"TradingKey - Amgen enters October with fresh Phase 3 pipeline wins, strong growth from Repatha and Imdelltra, and MariTide advancing across a broad obesity program.","market":"sg","thumbnail":"https://resource.tradingkey.com/uploads/20261008/AMGEN-7bfb3accd08d40ba905f9cb7227c2a13.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20261008/AMGEN-7bfb3accd08d40ba905f9cb7227c2a13.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262205484-amgen-amgn-stock-forecast-october-8-2026-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE0002141913.USD","BK4566","LU2112291526.USD","LU2468319806.SGD","IBB","IE00BJT1NW94.SGD","LU0109394709.USD","LU2242646821.SGD","BK4581","LU0889565916.HKD","LU1571399168.USD","LU0320765992.SGD","LU1061106388.HKD","LU2089984988.USD","TBXU","BK4585","BK4599","IBBQ","LU0868494617.USD","LU1023059063.AUD","LU0122379950.USD","IE00B4R5TH58.HKD","AMGN","IE00B2B36J28.USD","PBE","LU2242652126.USD","PJP","LU0289739699.SGD","BBH","LU1057294990.SGD","LU1983299246.USD","SG9999001440.SGD","BK4534","BK4139","BIB","IE00BFTCPJ56.SGD","LU0058720904.USD","BK4533","IE00BJJMRZ35.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158567840","title":"Zhongsheng Pharmaceutical's Class 1 Innovative Drug RAY1225 Injection Achieves Topline Analysis Results in Phase III Weight Loss Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1158567840","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158567840?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:40","pubTimestamp":1791459618,"startTime":"0","endTime":"0","summary":"Guangdong Zhongsheng Pharmaceutical Co.,Ltd. (002317.SZ) has announced that its controlled subsidiary, Guangdong Zhongsheng Ruichuang Biotechnology Co., Ltd., has obtained topline analysis data from...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK0077","06978","BMED","BK0188","BK0239","BK1574","MDTX","PSYK","IBBJ","LNGR","159992","BK1161","002317","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}